Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to 22% in this period. Decoding the charts, Nilesh Jain, Head Vice President, Equity Research, Technical and Derivatives at Centrum Broking, said that the CNX PHARMA index has formed an inverse head & shoulder pattern where the neckline is placed near 22,028 levels. A break above 22,200 will add further bullishness for the 22,500-22,800 level, while support is near 21550. Here are 5 stocks to buy from various brokerages:
Learn With ETMarkets: Can retail SIPs replace FII flows as India’s market backbone?
Systematic Investment Plans (SIPs) reached an all-time high of ₹27,269 crore in June 2025, reinforcing retail investor confidence and providing liquidity support amid foreign outflows.
July 19, 2025